This work established a robust framework for identifying and prioritizing high-confidence DARPin candidates for experimental validation, and identified mesothelin-targeting DARPin candidates with predicted structural confidences approaching those of a structurally validated picomolar-affinity binder.
These results establish motif scaffolding of surface-complementing seeds as an effective strategy for overcoming current limitations of de novo generative models, enabling the design of proteins that can engage challenging interface sites.
D. Britton, Dia A. Ghose, J. Halpin et al.· bioRxiv· 0 citations
Biomolecular binder design for peptides and antibodies requires generating diverse candidates that satisfy stringent three-dimensional geometric constraints while enabling affinity-oriented exploration under strong structural priors. In current generative models, the effective search space for structurally feasible binders is severely constrained, as the complexity of biochemical interactions is not explicitly encoded into a semantically grounded representation of viable molecular manifolds. To address this challenge, we propose Pretrained Representation Induced Molecular gEneration (PRIME), a unified generative framework for three-dimensional binder design across peptides and antibodies. PRIME grounds stochastic generation on frozen large-scale pretrained structural representations, inheriting robust physical priors to ensure structural feasibility without training a manifold from scratch. However, defining a feasible space alone is insufficient for effective exploration. Under commonly used isotropic perturbations, chain topology is ignored, allowing local noise to propagate into global structural distortions. To enable controlled exploration within the feasible space, we introduce Semantics-Preserving Exploratory Sampling (SPES), which integrates Graph Laplacian Spectral Noise to respect chain connectivity and Conditional Freedom Modulation to dynamically balance exploration with fidelity. By aligning stochastic exploration with structural semantics, PRIME enables diversity-enhanced generation without sacrificing geometric validity under the reported structural metrics, improving the empirical exploration--fidelity trade-off. PRIME achieves state-of-the-art performance on unified peptide and antibody benchmarks, effectively reconciling geometric validity with functional optimization under computational proxy metrics. The source code is available at https://github.com/simplaj/PRIME.
Zhihua Tian, Jiale Zhou, Rubo Wang et al.· Proceedings of the 32nd ACM...· 0 citations
Current structure-based drug design generative models often struggle to faithfully recapitulate genuine ligand-protein binding interactions. Instead, under the coupling of implicit learning architectures and biased training data, they tend to learn spurious statistical correlations. To address this, we propose EIP-Diff (Explicit Interaction-Prompted Diffusion), an architecture featuring a novel explicit interaction-prompt embedding mechanism that is better suited for real-world target-specific drug design. This architecture replaces biased implicit learning with explicit, residue-level biological guidance, thereby promoting more fine-grained geometric fidelity and more precise interaction-aware conditioning. To fully realize the capabilities of EIP-Diff and provide a reliable basis for performance evaluation, we further constructed CrystalData set, which provides higher-fidelity and less-biased structural supervision than existing data sets. This explicit architecture markedly improves distribution consistency: even when trained on the crossdocked data set, EIP-Diff achieves the highest alignment with authentic pharmacological distributions among evaluated models. Training on CrystalData set further enhances this alignment and improves 3D geometric accuracy, while retaining strong controllability, high chemical space coverage, and near-perfect uniqueness. In addition, target-based validation on KAT6A and YTHDC1 confirmed that EIP-Diff accurately recapitulates native-like binding modes. Furthermore, in a real-world drug design task against IDO1, we successfully designed a novel lead compound with nanomolar potency (IC50 = 0.31 nM). These results demonstrate that the EIP-Diff architecture can explicitly leverage experimentally derived structural data and biologically meaningful interaction information for target-specific molecular generation, thereby enabling its effective application to real-world structure-based drug design.
Huabin Du, Mingyang Wang, M. Luo et al.· Journal of the American Chem...· 0 citations
HEDGEHOG is introduced, a unified six-stage filtration benchmark that is inspired by industrial hit identification workflows and exposes a central limitation of current molecular generators: molecules that appear acceptable under isolated criteria rarely satisfy medicinal chemistry, synthesis, docking, and 3D pose filters simultaneously.
Daria A. Ryabchenko, Pavel Gurevich, S. Kadyrov et al.· arXiv.org· 0 citations
HighPlay2 is presented as a feasible framework for the early-stage design and screening of cyclic peptide candidates containing ncAAs, while further affinity maturation and experimental structural validation remain necessary.
Huitian Lin, Wentong Wang, Ning Zhu et al.· European journal of medicina...· 0 citations
A clear pattern is revealed in LLM spatial capabilities: while they still lag behind state-of-the-art approaches, they are promising and can handle multiple spatial constraints simultaneously, enabling scaling to heterogeneous setups.
Thomas MacDougall, Maksim Kuznetsov, Roman Schutski et al.· arXiv.org· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
